Orthofix Medical Inc. Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount
Orthofix Medical Inc. (OFIX) reported Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount of -$4.68 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-25.
Discontinued › Expense Statement › Operating Expenses
us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount · last filed 2019-02-25
- Orthofix Medical Inc. equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2018-12-31 was $0.00.
- Orthofix Medical Inc. equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2018-09-30 was -$4.45M.
- Orthofix Medical Inc. equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2018 was -$4.68M.
| Period end | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 3 month | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 6 month | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 9 month | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | -$4.45M derived: sum of 2 quarters · filed 2019-02-25 | -$4.68M 10-K · filed 2019-02-25 | |
| 2018-09-30 | -$4.45M 10-Q · filed 2018-10-29 | -$4.68M 10-Q · filed 2018-10-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |